44 results
PRE 14A
BDTX
Black Diamond Therapeutics Inc
12 Apr 24
Preliminary proxy
4:48pm
in order to leverage technology to enhance stockholder access to the Annual Meeting by enabling attendance and participation from any location. We believe … , that allow companies to distribute their proxy materials over the Internet under the “notice and access” approach. As a result, we are mailing to our
8-K
EX-10.1
fsb0693
18 Sep 23
Black Diamond Therapeutics Announces CEO Transition
7:12am
8-K
EX-10.2
5vrqr5m
18 Sep 23
Black Diamond Therapeutics Announces CEO Transition
7:12am
8-K
EX-1.1
g1d37uhtu7cr 8pgjxdg
30 Jun 23
Entry into a Material Definitive Agreement
4:03pm
424B5
sgyd40m62gmvi
30 Jun 23
Prospectus supplement for primary offering
4:01pm
424B5
32m5sd4md 65m265wr8t
29 Jun 23
Prospectus supplement for primary offering
6:02am
S-3
zwaipyiaguhue
14 Nov 22
Shelf registration
4:15pm
DEF 14A
opaej2
27 Apr 21
Definitive proxy
4:06pm
S-3ASR
w7i2tm l9fi
1 Feb 21
Automatic shelf registration
5:28pm